Prostate cancer trials in Latvia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Liepaja, Riga

  Age

  18 years and over

  People

  1,314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00